A detailed history of Dhjj Financial Advisors, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dhjj Financial Advisors, Ltd. holds 714 shares of BMY stock, worth $40,390. This represents 0.02% of its overall portfolio holdings.

Number of Shares
714
Previous 714 -0.0%
Holding current value
$40,390
Previous $29,000 24.14%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$40.25 - $52.99 $2,012 - $2,649
-50 Reduced 6.54%
714 $29,000
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $44,227 - $49,453
764 New
764 $44,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dhjj Financial Advisors, Ltd. Portfolio

Follow Dhjj Financial Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dhjj Financial Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Dhjj Financial Advisors, Ltd. with notifications on news.